Patents Assigned to Holoclara, Inc.
  • Patent number: 11845770
    Abstract: The present invention relates to methods of treating immune disorders and/or inflammation using certain modulator compounds. For example, the present invention provides methods of treating immune and/or inflammatory disorders by administering a composition comprising a compound having the structure of Formula (I).
    Type: Grant
    Filed: October 21, 2022
    Date of Patent: December 19, 2023
    Assignees: California Institute of Technology, Holoclara, Inc.
    Inventors: Brian M. Stoltz, Corey M. Reeves, Eduardo J. Martinez, Simon Bailey